275 related articles for article (PubMed ID: 16735376)
1. Spontaneous B cell hyperactivity in autoimmune-prone MRL mice.
Nijnik A; Ferry H; Lewis G; Rapsomaniki E; Leung JC; Daser A; Lambe T; Goodnow CC; Cornall RJ
Int Immunol; 2006 Jul; 18(7):1127-37. PubMed ID: 16735376
[TBL] [Abstract][Full Text] [Related]
2. FcgammaRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease.
Yajima K; Nakamura A; Sugahara A; Takai T
Eur J Immunol; 2003 Apr; 33(4):1020-9. PubMed ID: 12672068
[TBL] [Abstract][Full Text] [Related]
3. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice.
Merino R; Iwamoto M; Fossati L; Izui S
J Immunol; 1993 Dec; 151(11):6509-16. PubMed ID: 7902378
[TBL] [Abstract][Full Text] [Related]
4. B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity.
Chan OT; Madaio MP; Shlomchik MJ
J Immunol; 1999 Oct; 163(7):3592-6. PubMed ID: 10490951
[TBL] [Abstract][Full Text] [Related]
5. A genetic locus controlling aging-sensitive regression of B lymphopoiesis in an autoimmune-prone MRL/lpr strain of mice.
Nakatani K; Qu WM; Zhang MC; Fujii H; Furukawa H; Miyazaki T; Iwano M; Saito Y; Nose M; Ono M
Scand J Immunol; 2007 Dec; 66(6):654-61. PubMed ID: 17983422
[TBL] [Abstract][Full Text] [Related]
6. Responses of B cells from autoimmune mice to IL-5.
Umland SP; Go NF; Cupp JE; Howard M
J Immunol; 1989 Mar; 142(5):1528-35. PubMed ID: 2783944
[TBL] [Abstract][Full Text] [Related]
7. Cd72(c) is a modifier gene that regulates Fas(lpr)-induced autoimmune disease.
Xu M; Hou R; Sato-Hayashizaki A; Man R; Zhu C; Wakabayashi C; Hirose S; Adachi T; Tsubata T
J Immunol; 2013 Jun; 190(11):5436-45. PubMed ID: 23616572
[TBL] [Abstract][Full Text] [Related]
8. Tonic B cell activation by Radioprotective105/MD-1 promotes disease progression in MRL/lpr mice.
Kobayashi T; Takahashi K; Nagai Y; Shibata T; Otani M; Izui S; Akira S; Gotoh Y; Kiyono H; Miyake K
Int Immunol; 2008 Jul; 20(7):881-91. PubMed ID: 18492657
[TBL] [Abstract][Full Text] [Related]
9. Dissociation of severe lupus-like disease from polyclonal B cell activation and IL 2 deficiency in C3H-lpr/lpr mice.
Davidson WF; Roths JB; Holmes KL; Rudikoff E; Morse HC
J Immunol; 1984 Aug; 133(2):1048-56. PubMed ID: 6610701
[TBL] [Abstract][Full Text] [Related]
10. [Functional analysis of an autoantigen reactive B cell clone derived from MRL/MP-lpr/lpr mice].
Kobayashi K; Hamano T; Kakishita E
Ryumachi; 1996 Dec; 36(6):844-55. PubMed ID: 9122824
[TBL] [Abstract][Full Text] [Related]
11. A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice.
Chan O; Shlomchik MJ
J Immunol; 1998 Jan; 160(1):51-9. PubMed ID: 9551955
[TBL] [Abstract][Full Text] [Related]
12. Effects of the lpr mutation on elimination and inactivation of self-reactive B cells.
Rathmell JC; Goodnow CC
J Immunol; 1994 Sep; 153(6):2831-42. PubMed ID: 8077685
[TBL] [Abstract][Full Text] [Related]
13. Implication of allelic polymorphism of osteopontin in the development of lupus nephritis in MRL/lpr mice.
Miyazaki T; Ono M; Qu WM; Zhang MC; Mori S; Nakatsuru S; Nakamura Y; Sawasaki T; Endo Y; Nose M
Eur J Immunol; 2005 May; 35(5):1510-20. PubMed ID: 15832294
[TBL] [Abstract][Full Text] [Related]
14. Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice.
Takahashi K; Kozono Y; Waldschmidt TJ; Berthiaume D; Quigg RJ; Baron A; Holers VM
J Immunol; 1997 Aug; 159(3):1557-69. PubMed ID: 9233655
[TBL] [Abstract][Full Text] [Related]
15. B cell selection and allelic exclusion of an anti-DNA Ig transgene in MRL-lpr/lpr mice.
Roark JH; Kuntz CL; Nguyen KA; Mandik L; Cattermole M; Erikson J
J Immunol; 1995 May; 154(9):4444-55. PubMed ID: 7722301
[TBL] [Abstract][Full Text] [Related]
16. Transgenic expression of Fas in T cells blocks lymphoproliferation but not autoimmune disease in MRL-lpr mice.
Fukuyama H; Adachi M; Suematsu S; Miwa K; Suda T; Yoshida N; Nagata S
J Immunol; 1998 Apr; 160(8):3805-11. PubMed ID: 9558084
[TBL] [Abstract][Full Text] [Related]
17. Polyclonal B cell activation by a B cell differentiation factor, B151-TRF2. III. B151-TRF2 as a B cell differentiation factor closely associated with autoimmune disease.
Dobashi K; Ono S; Murakami S; Takahama Y; Katoh Y; Hamaoka T
J Immunol; 1987 Feb; 138(3):780-7. PubMed ID: 3543118
[TBL] [Abstract][Full Text] [Related]
18. T cell autoimmunity in Ig transgenic mice.
Shinde S; Gee R; Santulli-Marotto S; Bockenstedt LK; Clarke SH; Mamula MJ
J Immunol; 1999 Jun; 162(12):7519-24. PubMed ID: 10358207
[TBL] [Abstract][Full Text] [Related]
19. B cell genotype determines the fine specificity of autoantibody in lpr mice.
Kakkanaiah VN; Sobel ES; MacDonald GC; Cheek RL; Cohen PL; Eisenberg RA
J Immunol; 1997 Jul; 159(2):1027-35. PubMed ID: 9218626
[TBL] [Abstract][Full Text] [Related]
20. MRL/lpr and MRL+/+ macrophage DNA synthesis in the absence and the presence of colony-stimulating factor-1 and granulocyte-macrophage colony-stimulating factor.
Hamilton JA; Chan J; Byrne RJ; Bischof RJ; Jaworowski A; Kanagasundaram V
J Immunol; 1998 Dec; 161(12):6802-11. PubMed ID: 9862711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
